After receiving a $2 million NIH grant, a team of scientists at the School of Medicine looks to use cells to design a new type of safe, adaptable blood vessel graft for infants born with heart defects.
The National Institutes of Health (NIH) recently awarded Yibing Qyang, PhD, and his colleagues a $2+ million R01 grant to support research to create an